QUOTE AND NEWS
FiercePharma  Sep 1  Comment 
LONDON--Late last month, partners Eli Lilly and Boehringer Ingelheim announced that their SGLT2 diabetes med, Jardiance, had gone where no others had gone before. While its rivals had always either increased the risk of cardiovascular events...
The Hindu Business Line  Aug 31  Comment 
Shares of Aurobindo Pharma today gained 2.6 per cent as the company got approval from USFDA for key drugs.The company got USFDA approval for Raloxifene Hydrochloride tablet. It had also earl...
The Hindu Business Line  Aug 30  Comment 
Aurobindo Pharma has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Raloxifene Hydrochloride tablets. The approved drug is bio-equi...
FierceBiotech  Aug 28  Comment 
There are a lot of reasons why oncologists aren't exactly brimming with excitement at the idea of getting their hands on Eli Lilly's lung cancer drug necitumumab.
newratings.com  Aug 27  Comment 
INDIANAPOLIS (dpa-AFX) - The U.S. Food and Drug Administration (FDA) has approved Synjardy tablets, from Boehringer Ingelheim Pharmaceuticals Inc (BIPI) and Eli Lilly and Co (LLY), for the treatment of adults with type 2 diabetes. Synjardy is...
Reuters  Aug 27  Comment 
* Adocia and Eli Lilly initiate new PHASE 1B study of repeated administration of Ultra-Rapid BioChaperone Lispro in patients with type 1 diabetes
Benzinga  Aug 26  Comment 
Gilead Sciences, Inc. (Nasdaq: GILD) today announced detailed results from the AMBITION study (a randomized, double-blind, multicenter study of first-line combination therapy with AMBrIsentan and Tadalafil in patients with pulmonary arterial...
FiercePharma  Aug 26  Comment 
Eli Lilly has fought tooth and nail to protect a patent for its blockbuster cancer drug Alimta, chalking up some victories in the U.S. despite setbacks overseas. Now the company is celebrating a big win as a federal court ruled in its favor,...
Benzinga  Aug 25  Comment 
Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's favor regarding infringement of the vitamin regimen patent for Alimta® (pemetrexed for injection)....
FiercePharma  Aug 20  Comment 
Eli Lilly has been making its fair share of courtroom appearances lately, battling claims over withdrawal symptoms linked to its blockbuster antidepressant in the U.S. and defending a patent for a lung cancer drug in Europe. In its latest legal...




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki